<DOC>
	<DOCNO>NCT00570154</DOCNO>
	<brief_summary>Background : Patients pre-diabetic adult onset ( type 2 ) diabetes significantly great risk develop heart , blood vessel , kidney disease . Recent study show abnormality white blood cell function may increase chance develop insulin resistance , underlie problem diabetic pre-diabetic patient . Objectives : To determine level insulin sensitivity select volunteer . To compare white blood cell non-diabetic , pre-diabetic , type 2 ( adult onset ) diabetic volunteer evaluate possible difference white blood cell function . Eligibility : Individuals 21 60 year age ( 1 ) non-diabetic , ( 2 ) pre-diabetic ( glucose intolerant insulin resistant ) , ( 3 ) type 2 diabetes control diet and/or medication insulin . Design : Evaluations treatment : - Blood test , include screen procedure blood-transmitted disease hepatitis B C , insulin sensitivity glucose tolerance test , liver kidney function test . - Pregnancy test woman childbearing age . Two test perform study period : - Glucose tolerance test determine well body us glucose . - Blood drawn study white blood cell . Participants financially compensate time spend study .</brief_summary>
	<brief_title>Relation White Blood Cell Function Diabetes</brief_title>
	<detailed_description>Type II diabetes mellitus rapidly become global pandemic deleterious impact cardiovascular morbidity mortality . Understanding pathophysiology important development future therapeutic intervention . Interestingly , mitochondrial dysfunction skeletal muscle adipose tissue early event development type II diabetes mellitus propose play role exacerbate insulin resistance . The genetic disruption macrophage mitochondrial biology preclinical study result development insulin resistance concurrent mitochondrial dysfunction peripheral tissue include skeletal muscle liver . Whether disruption mitochondrial function evident human mononuclear cell unknown . We propose disruption mitochondrial function circulate cell may contribute peripheral insulin resistance may also evoke myriad vascular complication associate diabetes . To test assumption , propose initial proof concept study evaluate mitochondrial biology circulate monocyte normal volunteer , pre-diabetic diabetic subject ass whether mitochondrial disruption/dysfunction evolve progression type II diabetes . In parallel , gene expression proteomic analysis perform evaluate whether development insulin resistance diabetes confers specific modulation biological signature monocytes disease progression . To delineate concept evaluate study subject ' glucose tolerance insulin sensitivity draw blood examine peripheral monocyte . Biological readouts include : 1 ) quantification mitochondrial genomic electron transfer chain content ; 2 ) determination mitochondrial reactive oxygen specie capacity defenses ; 3 ) pattern monocyte differentiation 4 ) unbiased assessment monocyte gene expression proteome . If mitochondrial hypothesis operational , study show mitochondrial disruption/dysfunction generalize find type II diabetes . This would establish target modification mitochondrial function various tissue/cell type novel strategy prevention and/or reversal insulin resistance diabetes .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>INCLUSION CRITERIA ( young group ) Adults old 21 year less 40 year Subjects must either : Insulin sensitivity fast blood glucose le 100 mg/dl 2hour post oral glucose tolerance test blood glucose le 140 mg/dl Insulin resistance define fast blood sugar great equal 100mg/dl less 125 mg/dl and/or 2hour post oral glucose tolerance test blood glucose great 140 mg/dl less 200 mg/dl . Subject understands protocol provide write , informed consent . INCLUSION CRITERIA ( middle age group ) Adults great equal 40 year less equal 60 year Subjects must either : Insulin sensitivity fast blood glucose le 100 mg/dl 2hour post oral glucose tolerance test blood glucose le 140 mg/dl Insulin resistance define fast blood sugar great equal 100mg/dl less 125 mg/dl and/or 2hour post oral glucose tolerance test blood glucose great 140 mg/dl less 200 mg/dl . Type II diabetes define fast blood sugar great 125 mg/dl and/or 2hour post oral glucose tolerance test blood glucose great 200 mg/dl untreated and/or subject oral hypoglycemic agent therapy HbA1c great 6.7 percent . Subject understands protocol provide write , informed consent . EXCLUSION CRITERIA ( study volunteer subject ) Uncontrolled hypertension therapy Betablocker History heart failure ( ejection fraction le 55 percent echocardiogram ) , unstable coronary artery disease symptomatic peripheral arterial disease require change medication medical intervention precede 3 month . Insulindependant diabetes mellitus current use thiazolidinediones Women childbearing age unless recent pregnancy test negative breast feeding . Serum creatinine great 2.5 mg/dl Liver transaminase level great 2.5 time upper limit normal History cancer last 5 year Active inflammatory disease , infection , abnormal white blood cell differential Enrollment drug study within last 30 day BMI great 35 middle age group great 30 young subject</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 19, 2009</verification_date>
	<keyword>Mitochondrial Function Monocytes</keyword>
	<keyword>Macrophages Diabetes Insulin Resistance</keyword>
	<keyword>Peripheral Blood Mononuclear Cells</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Monocyte</keyword>
	<keyword>Macrophages</keyword>
	<keyword>Proteome</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Insulin Resistance</keyword>
	<keyword>Insulin Sensitivity</keyword>
	<keyword>Pre-Diabetes</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>